Drug-induced dyskinesia in primates rendered hemiparkinsonian by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
- 1 May 1989
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 90 (3) , 307-314
- https://doi.org/10.1016/0022-510x(89)90117-2
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeysSynapse, 1988
- Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Journal of the Neurological Sciences, 1987
- TIMING OF LEVODOPA THERAPY: EVIDENCE FROM MPTP-TREATED PRIMATESThe Lancet, 1987
- Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor densityBrain Research, 1986
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985
- L-DOPA reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatumJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- The pharmacological evaluation of pergolide mesylate as a potential anti-Parkinson agentNeuropharmacology, 1980
- Experimental torticollis in the monkey produced by unilateral 6-hydroxydopamine brain lesionsBrain Research, 1978